Comparative determination of the efficacy of bispyridinium oximes in paraoxon poisoning / Usporedno određivanje učinkovitosti bispiridinijevih oksima pri trovanju paraoksonom

1. Kwong TC. Organophosphate pesticides: biochemistry and clinical toxicology. Ther Drug Monit 2002;24:144-9. PMID: 1180573510.1097/00007691-200202000-00022Search in Google Scholar

2. Macllwain C. Study proves Iraq used nerve gas. Nature 1993;363:3. doi: 10.1038/363003b010.1038/363003b0Search in Google Scholar

3. Nagao M, Takatori T, Matsuda Y, Nakajima M, Iwase H, Iwadate K. Definitive evidence for the acute sarin poisoning diagnosis in the Tokyo subway. Toxicol Appl Pharmacol 1997;144:198-203. PMID: 916908510.1006/taap.1997.8110Search in Google Scholar

4. Gunnell D, Eddleston M, Phillips MR, Konradsen F. The global distribution of fatal pesticide self-poisoning: systematic review. BMC Public Health 2007;7:357. doi: 10.1186/1471-2458-7-35710.1186/1471-2458-7-357Search in Google Scholar

5. Lotti M. Clinical toxicology of anticholinesterase agents in humans. In: Krieger R, editor. Handbook of pesticide toxicology. San Diego: Academic Press; 2001. p. 1043-85.10.1016/B978-012426260-7.50054-9Search in Google Scholar

6. Somani SM, Husain K. Low-level nerve agent toxicity under normal and stressful conditions. In: Somani SM, Romano Jr. JA, editors. Chemical warfare agents: toxicity at low levels. Boca Raton (FL): CRS Press LLC; 2001. p. 83-120.10.1201/9781420041576.ch3Search in Google Scholar

7. Antonijević B, Stojiljković MP. Unequal efficacy of pyridinium oximes in acute organophosphate poisoning. Clin Med Res 2007;5:71-82. doi: 10.3121/cmr.2007.70110.3121/cmr.2007.701Search in Google Scholar

8. Kuča K, Musilek K, Jun D, Bajgar J, Kassa J. Novel oximes. In: Gupta RC, editor. Handbook of toxicology of chemical warfare agents. London: Elsevier; 2009. p. 997-1021.10.1016/B978-012374484-5.00066-3Search in Google Scholar

9. Barelli A, Soave PM, Del Vicario M, Barelli R. New experimental oximes in the management of organophosphorus pesticides poisoning. Minerva Anestesiol 2011;77:1197-203. PMID: 21799476Search in Google Scholar

10. Masson P. Evolution of and perspectives on therapeutic approaches to nerve agent poisoning. Toxicol Lett 2011;206:5-13. doi: 10.1016/j.toxlet.2011.04.00610.1016/j.toxlet.2011.04.006Search in Google Scholar

11. Kuča K, Bielavský J, Cabal J, Bielavská M. Synthesis of a potential reactivator of acetylcholinesterase 1-(4- hydroxyiminomethylpyridinium)-3 -(carbamoylpyridinium)- propane dibromide. Tetrahedron Lett 2003;44:3123-5. doi: 10.1016/S0040-4039(03)00538-010.1016/S0040-4039(03)00538-0Search in Google Scholar

12. Kuča K, Bielavský J, Cabal J, Kassa J. Synthesis of a new reactivator of tabun-inhibited acetylcholinesterase. Bioorg Med Chem Lett 2003;13:3545-7. doi: 10.1016/S0960-894X(03)00751-010.1016/S0960-894X(03)00751-0Search in Google Scholar

13. Musilek K, Holas O, Kuča K, Jun D, Dohnal V, Doležal M. Synthesis of asymmetrical bispyridinium compounds bearing cyano moiety and evaluation of their reactivation activity against tabun and paraoxon-inhibited acetylcholinesterase. Bioorg Med Chem Lett 2006;16:5673-6. doi: 10.1016/j. bmcl.2006.08.011Search in Google Scholar

14. Musilek K, Kuča K, Jun D, Dohnal V, Doležal M. Synthesis of the novel series of bispyridinium compounds bearing (E)-but-2-ene linker and evaluation of their reactivation activity against chlorpyrifos-inhibited acetylcholinesterase. Bioorg. Med Chem Lett 2006;16:622-7. doi: 10.1016/j. bmcl.2005.10.059Search in Google Scholar

15. Musilek K, Jun D, Cabal J, Kassa J, Gunn-Moore F, Kuča K. Design of a potent reactivator of tabun-inhibited acetylcholinesterase-synthesis and evaluation of (E)-1- (4 -carbamoylpyridinium)-4-(4-hydroxyiminomethylpyridi nium)-but-2-ene dibromide (K203). J Med Chem 2007;50:5514-8. doi: 10.1021/jm070653r10.1021/jm070653r17924614Search in Google Scholar

16. Kuča K, Stodulka P, Hrabinova M, Hanusova P, Jun D, Doležal B. Convenient preparation of the oxime HI-6 (dichloride and DMS) - antidote against nerve agents. Def Sci J 2008;58:399-404.10.14429/dsj.58.1660Search in Google Scholar

17. Thompson WR. Use of moving averages and interpolation to estimate median effective dose. Bacteriol Rev 1947;11:115-45. PMCID: PMC44091510.1128/br.11.2.115-145.1947Search in Google Scholar

18. Weil CS. Tables for convenient calculation of medianeffective dose (LD50 or ED50) and instruction in their use. Biometrics 1952;8:249-63.10.2307/3001557Search in Google Scholar

19. Čalić M, Lucić Vrdoljak A, Radić B, Jelić D, Jun D, Kuča K, Kovarik Z. In vitro and in vivo evaluation of pyridinium oximes: Mode of interaction with acetylcholinesterase, effect on tabun- and soman-poisoned mice and their cytotoxicity. Toxicology 2006;219:85-96. doi: 10.1016/j.tox.2005.11.00310.1016/j.tox.2005.11.00316332406Search in Google Scholar

20. Berend S, Lucić Vrdoljak A, Radić B, Kuča K. New bispyridinium oximes: In vitro and in vivo evaluation of their biological efficiency in soman and tabun poisoning. Chem Biol Interact 2008;175:413-6. doi: 10.1016/j.cbi.2008.04.03110.1016/j.cbi.2008.04.03118547553Search in Google Scholar

21. Kovarik Z, Lucić Vrdoljak A, Berend S, Katalinić M, Kuča K, Musilek K, Radić B. Evaluation of oxime K203 as antidote in tabun poisoning. Arh Hig Rada Toksikol 2009;60:19-26. doi: 10.2478/10004-1254-60-2009-189010.2478/10004-1254-60-2009-189019329372Search in Google Scholar

22. Park NJ, Jung YS, Musilek K, Jun D, Kuča K. Potency of several structurally different acetylcholinesterase reactivators to reactivate house fly and bovine acetylcholinesterases inhibited by paraoxon and DFP. Bull Korean Chem Soc 2006;27:1401-4.10.5012/bkcs.2006.27.9.1401Search in Google Scholar

23. Petroianu GA, Arafat K, Kuča K, Kassa J. Five oximes (K-27, K-33, K-48, BI-6 and methoxime) in comparison with pralidoxime: in vitro reactivation of red blood cell acetylcholinesterase inhibited by paraoxon. J Appl Toxicol 2006;26:64-71. doi: 10.1002/jat.110810.1002/jat.110816193529Search in Google Scholar

24. Petroianu GA, Nurulain SM, Nagelkerke N, Al-Sultan MA, Kuča K, Kassa J. Five oximes (K-27, K-33, K-48, BI-6 and methoxime) in comparison with pralidoxime: survival in rats exposed to the organophosphate paraoxon. J Appl Toxicol 2006;26:262-8. doi: 10.1002/jat.114310.1002/jat.114316583462Search in Google Scholar

25. Petroianu GA, Kalasz H. Comparison of the ability of pyridinium aldoximes to reactivate human RBC cholinesterases inhibited by ethyl- and methyl-paraoxon. Curr Org Chem 2007;11:1624-34. doi: 10.2174/ 138527212800564277 10.2174/138527207783221183Search in Google Scholar

26. Lorke DE, Hasan MY, Arafat K, Kuča K, Musilek K, Schmitt A, Petroianu GA. In vitro oxime reactivation of red blood cell acetylcholinesterase inhibitied by diisopropylfluorophosphate (DFP). J Appl Toxicol 2008;28:422-9. doi: 10.1002/jat.134410.1002/jat.134418344198Search in Google Scholar

27. Musilova L, Kuča K, Jung YS, Jun D. In vitro oxime assisted reactivation of paraoxon-inhibited human acetylcholinesterase and butyrylcholinesterase. Clin Toxicol 2009;47:545-50. doi: 10.1080/1556365090305891410.1080/1556365090305891419586353Search in Google Scholar

28. Kuča K, Musilek K, Jun D, Pohanka M, Kumar Ghosh K, Hrabinova M. Oxime K027: novel low-toxic candidate for the universal reactivator of nerve agent- and pesticideinhibited acetylcholinesterase. J Enzyme Inhib Med Chem 2010;25:509-12. doi: 10.3109/1475636090335756910.3109/1475636090335756920192902Search in Google Scholar

29. Gupta B, Sharma R, Singh N, Kuča K, Acharya JR, Ghosh KK. In vitro reactivation kinetics of paraoxon- and DFPinhibited electric eel AChE using mono- and bis-pyridinium oximes. Arch Toxicol 2014;88:381-90. doi: 10.1007/s00204-013-1136-z10.1007/s00204-013-1136-z24065055Search in Google Scholar

30. Yousefpour M, Bahrami F, Behboodi BS, Khoshbaten A, Asgari A. Paraoxon-induced ultrastructural growth changes of rat cultured hippocampal cells in neurobasal/B27. Toxicology 2006;217:221-7. doi:10.1016/j.tox.2005.09.01810.1016/j.tox.2005.09.01816289293Search in Google Scholar

31. Kovarik Z, Čalić M, Bosak A, Šinko G, Jelić D. In vitro evaluation of aldoxime interactions with human acetylcholinesterase. Croat Chem Acta 2008;81:47-57.Search in Google Scholar

32. Petroianu GA, Lorke DE. Pyridinium oxime reactivators of cholinesterase inhibited by diisopropylfluorophosphate (DFP): Predictive value of in vitro testing for in vivo efficacy. Mini Rev Med Chem 2008;8:1328-42. doi: 10.2174/ 13895570878636955510.2174/13895570878636955518991751Search in Google Scholar

33. Bhattacharjee AK, Kuča K, Musilek K, Gordon RK. In silico pharmacophore model for tabun-inhibited acetylcholinesterase reactivators: a study of their stereoelectronic properties. Chem Res Toxicol 2010;23:26-36. doi: 10.1021/tx900192u10.1021/tx900192u20028185Search in Google Scholar

34. Dawson RM. Review of oximes available for the treatment of nerve agent poisoning. J Appl Toxicol 1994;14:317-31. doi: 10.1002/jat.255014050210.1002/jat.25501405027822680Search in Google Scholar